1304
Vol. 50, No. 9
Chart 1. Total Synthesis of (Ϯ)-Pandamarilactonine-A and -C
N., Nonato M. G., J. Am. Chem. Soc., 122, 8635—8639 (2000).
6) Takayama H., Ichikawa T., Kitajima M., Aimi N., Lopez D., Nonato
M. G., Tetrahedron Lett., 42, 2995—2996 (2001).
7) Takayama H., Ichikawa T., Kitajima M., Nonato M. G., Aimi N., J.
Nat. Prod., 64, 1224—1225 (2001).
hyde (9) with the siloxyfuran (10) in the presence of
BF3·Et2O; ii) dehydration of the resultant aldol adduct (11)
with trifluoromethanesulfonic anhydride and pyridine11)
(48% overall yield); and iii) halogen exchange of (12) with
NaI in acetone (47% yield). The thus-obtained C9 unit (13)
consisted of Z and E isomers in the ratio of 4.6 : 1, and was
then condensed with secondary amine (8) in acetonitrile in
the presence of K2CO3 to give two pandamarilactonines in
33% and 7% yields, both of which possessed the threo form
at the C-14 and C-15 positions. The major synthetic product
having the Z configuration was completely identical with nat-
ural pandamarilactonine-A and the minor one having the E
configuration was identical with natural pandamarilactonine-
C, respectively, by direct comparison of their chromato-
8) Pandamarilactonine-C (1): An amorphous powder, [a]D23 ϩ26.2° (cϭ
0.99, CHCl3), UV (MeOH) lmax nm (log e): 275 (4.23), 220 (sh), 201
(3.67). IR (neat) nmax cmϪ1: 1758 (lactone). FAB-MS (NBA) m/z; 318
[MϩH]ϩ. HR-FAB-MS (NBA): Calcd for C18H23NO4: 318.1704,
Found 318.1691. 1H-NMR (500 MHz, CDCl3) d: 7.31 (1H, dd, Jϭ0.9,
1.5 Hz, H-4), 7.04 (1H, d-like, Jϭ1.5 Hz, H-16), 5.64 (1H, dd, Jϭ8.2,
8.5 Hz, H-6), 4.80 (1H, ddd, Jϭ1.8, 1.8, 5.5 Hz, H-15), 3.12 (1H, dd-
like, Jϭ6.7, 7.3 Hz, H-11), 2.91 (1H, ddd, Jϭ7.9, 8.2, 11.9 Hz, H-9),
2.78 (1H, m, H-14), 2.45 (1H, ddd, Jϭ5.8, 7.0, 11.9 Hz, H-9), 2.35
(1H, ddd, Jϭ7.0, 8.2, 14.7 Hz, H-7), 2.25 (2H, m, H-7 and H-11), 2.02
(3H, d, Jϭ0.9 Hz, H3-21), 1.94 (3H, d-like, Jϭ1.8 Hz, H3-20), 1.71—
1.82 (2H, m, H-12, H-13), 1.62—1.68 (3H, m, H2-8, H-13), 1.45 (1H,
m, H-12). 13C-NMR (125 MHz, CDCl3) d: 174.2 (C-18), 171.0 (C-2),
148.7 (C-5), 146.7 (C-16), 131.3 (C-17), 130.3 (C-4), 129.1 (C-3),
113.4 (C-6), 83.8 (C-15), 65.6 (C-14), 55.2 (C-9), 54.2 (C-11), 29.1
(C-8), 26.1 (C-12), 24.2 (C-7), 23.8 (C-13), 10.8 (C-20, C-21).
9) Pandamarilactonine-D (2): An amorphous powder, [a]D25 0° (cϭ0.21,
CHCl3), UV (MeOH) lmax nm (log e): 276 (4.38), 234 (sh), 203 (4.30).
IR (neat) nmax cmϪ1: 1760 (lactone). FAB-MS (NBA) m/z; 318 [Mϩ
H]ϩ. HR-FAB-MS (NBA): Calcd for C18H23NO4: 318.1704, Found
318.1704. 1H-NMR (500 MHz, CDCl3) d: 7.35 (1H, m, H-4), 6.99
(1H, dd, Jϭ1.5, 1.7 Hz, H-16), 5.60 (1H, dd, Jϭ8.3, 8.8 Hz, H-6), 4.74
(1H, m, H-15), 3.08 (1H, m, H-11), 2.77 (1H, m, H-9), 2.72 (1H, m,
H-14), 2.42 (1H, m, H-9), 2.29 (2H, m, H2-7), 2.25 (1H, m, H-11),
2.01 (3H, m, H3-21), 1.94 (3H, dd-like, Jϭ1.5, 2.0 Hz, H3-20), 1.78—
1.92 (4H, m, H2-12, H2-13), 1.63 (2H, m, H2-8). 13C-NMR (125 MHz,
CDCl3) d: 174.3 (C-18), 171.0 (C-2), 149.0 (C-5), 147.1 (C-16), 131.0
(C-17), 133.9 (C-4), 130.3 (C-3), 113.3 (C-6), 83.0 (C-15), 65.9 (C-
14), 55.1 (C-9), 54.0 (C-11), 28.7 (C-8), 26.3 (C-12), 24.0 (C-7), 23.9
(C-13), 10.8 (C-20), 10.7 (C-21).
1
graphic behavior, as well as their mass, and H- and 13C-
NMR spectra. Based on the results of this synthetic study, the
structures of pandamarilactonine-C, -D, -A, and -B were un-
ambiguously established to be formulas 1 to 4, respectively.
The stereochemistry at the vicinal centers in pandamarilacto-
nine-A and -B was analyzed by spectroscopic methods and
the structures having the erythro-form for pandamarilacto-
nine-A and the threo-form for B have been proposed.5) How-
ever, they should be revised as above.
Acknowledgments This work was supported in part by a Grant-in-Aid
(No. 14370718) for Scientific Research from the Ministry of Education,
Culture, Sports, Science and Technology, Japan.
Rerefercnes and Notes
1) Tan M., “Philippine Medicinal Plants in Common Use: Their Phyto-
chemistry and Pharmacology,” AKAP, Quezon City, 1980.
2) Peungvicha P., Thirawarapan S. S., Watanabe H., Biol. Pharm. Bull.,
19, 364—366 (1996).
3) Peungvicha P., Thirawarapan S. S., Watanabe H., Jpn. J. Pharmacol.,
78, 395—398 (1998).
4) Peungvicha P., Temsiririrkkul R., Prasain J. K., Tezuka Y., Kadota S.,
Thirawarapan S. S., Watanabe H., J. Ethnopharmacol., 62, 79—84
(1998).
10) Martin S. F., Barr K. J., Smith D. W., Bur S. K., J. Am. Chem. Soc.,
121, 6990—6997 (1999).
11) Bruckner R., Chem. Commun., 2001, 141—152 (2001), and references
cited therein.
12) Note added in proof: After submission of the paper, a total synthesis of
pandamarilactonine-A and -B was published, Busque F., March P.,
Figueredo M., Font J., Sanfeliu E., Tetrahedron Lett., 43, 5583—5585
(2002).
5) Takayama H., Ichikawa T., Kuwajima T., Kitajima M., Seki H., Aimi